AN2 Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AN2 Therapeutics, Inc. has filed 381 SEC EDGAR filings since 24 Sep 2021

SEC filing history

Showing 26-50 of 381 matching filings.

Per page
25
Current page
2
EFFECT File 333-294956

EFFECT filing

Filing date
20 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-294956

424B3

Filing date
20 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-294956

424B5

Filing date
20 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-294956

UPLOAD filing

Filing date
15 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Apr 2026
Reporting date
10 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Apr 2026
Reporting date
10 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Apr 2026
Reporting date
10 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-577698

D filing

Filing date
25 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Mar 2026
Reporting date
19 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .